ROIVANT SCIENCES LTD. purchased 17.2% of their position (16.67M shares) of IMMUNOVANT, INC. on the open market
Open‑market purchase worth $350.00M — a significant purchase. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 12/12/2025ACC: 0001140361-25-045409
+16.67M
Net shares
Net buyer
$350.00M
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
16.67M acquired
Non-Derivative Transactions1
Common Stock, $0.0001 par value per share
Direct
Shares
+16.67M
Price / share
$21.00
Trade value
$350M
% of position
17.2%
12/12/2025
96.65M→113.32M
Total
Net shares
+16.67M
Net value
$350M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.0001 par value per share Direct | 12/12/2025 | P · Purchase | +16.67M | $21.00 | $350M | 17.2% | 96.65M | 113.32M |
| Total | +16.67M | $350M | ||||||
Derivative Transactions0
No derivative transactions reported